Discover
KALV
KalVista Pharmaceuticals Inc
27.00
2 x 19.43
2 x 34.54
bid
ask
+
27.00
0.00%
2 @ 04:00 PM
26.99 -0.01 (0.04%)
| Ytd | 67.18% | |
| 1y | 106.26% |
26.98
day range
27.00
9.83
52 week range
27.00
| Open | 26.99 | Prev Close | Low | 26.98 | High | 27.00 | Mkt Cap | 1.44B | |
| Vol | 4.26M | Avg Vol | 3.63M | EPS | -3.94 | P/E | N/A | Forward P/E | 15.82 |
| Beta | -0.11 | Short Ratio | 0.94 | Inst. Own | 136.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 24.43 | 200-d Avg | 17.09 | 1yr Est | 27.00 |
| Income Statement | |||
| Total Revenue | 40.86M | ||
| Revenues (USD) | 40.86M | ||
| Cost of Revenue | 3.09M | ||
| Gross Profit | 37.77M | ||
| Operating Expenses | 61.22M | ||
| Research and Development Expense | 12.42M | ||
| Selling, General and Administrative Expense | 48.80M | ||
| Operating Income | -23.44M | ||
| Interest Expense | 5.59M | ||
| Net Income | -23.49M | ||
| Net Income Common Stock | -23.49M | ||
| Net Income Common Stock (USD) | -23.49M | ||
| Consolidated Income | -23.49M | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -17.90M | ||
| Earning Before Interest & Taxes (USD) | -17.90M | ||
| Weighted Average Shares | 54.58M | ||
| Weighted Average Shares Diluted | 54.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 213.77M | ||
| Cash and Equivalents (USD) | 213.77M | ||
| Investments | 71.26M | ||
| Investments Current | 71.26M | ||
| Trade and Non-Trade Receivables | 9.90M | ||
| Current Assets | 314.21M | ||
| Property, Plant & Equipment Net | 12.26M | ||
| Total Assets | 328.92M | ||
| Total Debt | 149.81M | ||
| Current Liabilities | 60.82M | ||
| Debt Non-Current | 149.81M | ||
| Total Liabilities | 348.57M | ||
| Accumulated Retained Earnings (Deficit) | -786.18M | ||
| Accumulated Other Comprehensive Income | -7.12M | ||
| Shareholders Equity | -19.65M | ||
| Shareholders Equity (USD) | -19.65M | ||
| Assets Non-Current | 14.71M | ||
| Total Debt (USD) | 149.81M | ||
| Deferred Revenue | 22.19M | ||
| Inventory | 4.00M | ||
| Liabilities Non-Current | 287.75M | ||
| Trade and Non-Trade Payables | 8.05M | ||
| Tax Assets | 7.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 513.00K | ||
| Net Cash Flow from Financing | 1.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -15.57M | ||
| Capital Expenditure | -203.00K | ||
| Issuance (Purchase) of Equity Shares | 1.47M | ||
| Net Cash Flow from Investing | -901.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -698.00K | ||
| Net Cash Flow from Operations | -14.45M | ||
| Effect of Exchange Rate Changes on Cash | -1.68M | ||
| Share Based Compensation | 5.07M | ||